Regulation of type IV collagen degrading enzyme by cortisol during human skin fibroblast growth.
The effects of cortisol on type IV collagenolytic enzyme activity were studied in human skin fibroblast cultures. Cortisol reduced the production of the enzyme, both in normally dividing fibroblasts, and also when the secretion was induced by the administration of the tumor promoter 12-O-tetradecanoyl phorbol 13-acetate (TPA) to the subconfluent culture. TPA decreased the glucocorticoid receptor activity and augmented the cGMP content of subconfluent fibroblasts. Type IV collagenolytic activity appeared to be correlated positively with the cGMP/cAMP ratio, and negatively with the glucocorticoid receptor activity, and the activity was increased by the addition of dibutyryl cGMP. This suggests that this enzyme may at least partly be under glucocorticoid control during fibroblast growth, and that TPA may to some degree act via the inactivation of glucocorticoid receptors.
Salo
T
T
Oikarinen
J
J
D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D003995:Dibutyryl Cyclic GMP / Q000494:pharmacology; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D003012:Microbial Collagenase / Q000378:metabolism*; D011965:Receptors, Glucocorticoid / Q000378:metabolism; D012867:Skin / Q000166:cytology / Q000201:enzymology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D011965:Receptors, Glucocorticoid; D003995:Dibutyryl Cyclic GMP; D000242:Cyclic AMP; D003012:Microbial Collagenase; D006152:Cyclic GMP; D013755:Tetradecanoylphorbol Acetate; D006854:Hydrocortisone